mous
hepat
viru
mhv
coronaviru
caus
enceph
demyelin
suscept
rodent
previou
investig
shown
mhv
spike
protein
critic
determin
viral
tropism
pathogen
mice
rat
understand
molecular
basi
mhv
neuropathogenesi
studi
spike
protein
gene
sequenc
sever
neutralizationresist
variant
jhm
strain
mhv
select
monoclon
antibodi
mab
specif
protein
found
variant
select
mab
primarili
caus
demyelin
singl
point
mutat
nucleotid
nt
compar
parent
jhm
viru
predominantli
caus
enceph
site
subunit
protein
contrast
variant
select
mab
primarili
caus
enceph
two
point
mutat
nt
sl
subunit
final
doubl
mutant
select
mab
attenu
respect
virul
abil
caus
demyelin
delet
span
nt
sl
point
mutat
nt
conclud
least
two
region
protein
contribut
neuropathogen
mhv
also
isol
partial
revert
partial
resist
mab
retain
neuropathogen
variant
revert
retain
mutat
nt
secondsit
mutat
nt
confirm
nt
contribut
pathogen
phenotyp
mhv
compar
result
mhv
variant
isol
laboratori
mutat
site
gene
yet
retain
demyelin
abil
suggest
abil
jhm
virus
induc
demyelin
determin
interact
multipl
site
gene
rather
characterist
singl
uniqu
site
studi
also
reveal
possibl
presenc
microheterogeneitv
gene
sequenc
particularli
sl
region
virus
sequenc
microheterogen
may
also
contribut
differ
biolog
properti
mous
hepat
viru
mhv
prototyp
member
coronavirida
viru
envelop
contain
singlestrand
positivesens
nonseg
rna
genom
kb
length
lai
stohlman
pachuk
et
al
lee
er
al
viru
particl
contain
three
envelop
glycoprotein
intern
nucleocapsid
protein
n
spike
protein
kda
form
peplom
virion
surfac
respons
viral
attach
cellular
receptor
elicit
neutral
antibodi
induct
celltocel
fusion
collin
eta
sturman
eta
alter
protein
result
chang
viral
pathogen
demonstr
neutralizationescap
mutant
se
current
address
depart
neurolog
medic
microbiolog
immunolog
school
medicin
univers
wisconsin
madison
madison
wi
correspond
reprint
request
address
q
academ
press
inc
lect
monoclon
antibodi
mab
specif
protein
fleme
et
fleme
et
dalziel
et
al
wege
et
furthermor
passiv
immun
sspecif
monoclon
antibodi
also
alter
viral
neuropathogen
buchmeier
et
protein
cleav
two
glycoprotein
subunit
sl
cleavag
carri
cellular
proteas
probabl
requir
virusinduc
cell
fusion
storz
et
yoshikura
tajima
sturman
et
al
protein
translat
mrna
repres
transcript
gene
gene
locat
roughli
kb
rna
genom
lai
complet
sequenc
gene
report
three
strain
mhv
name
luytj
et
jhm
schmidt
et
equival
jhm
use
laboratori
parker
et
appear
gene
sequenc
differ
mhv
strain
differ
significantli
variou
degre
delet
substitut
infect
central
nervou
system
cn
rodent
mhv
particularli
jhm
strain
use
model
system
studi
human
demyelin
diseas
multipl
sclerosi
parent
jhm
strain
show
tropism
neuron
glial
cell
caus
enceph
chronic
demyelin
weiner
tropism
mhv
mainli
determin
properti
protein
sinc
outermost
compon
viral
envelop
interact
cellular
receptor
also
immunodomin
compon
interact
host
immun
system
sturman
holm
role
structur
protein
viral
pathogenesi
less
well
understood
passiv
immun
mab
specif
n
membran
protein
also
chang
viral
pathogen
fleme
et
nakanaga
et
previous
isol
sever
neutralizationresist
variant
jhm
use
mab
specif
protein
fleme
et
variant
show
strikingli
differ
capabl
parent
jhm
viru
caus
demyelin
enceph
rodent
fleme
eta
fleme
eta
parent
viru
caus
enceph
variant
select
one
neutral
mab
lower
virul
caus
demyelin
variant
select
two
mab
caus
neither
enceph
demyelin
fleme
et
al
fleme
et
al
base
studi
hypothes
mab
identifi
specif
encephalitisdetermin
site
mab
identifi
specificdemyelinationdetermin
site
protein
altern
consid
possibl
singl
linear
determin
might
necessari
suffici
caus
jhminduc
demyelin
demyelin
would
depend
sever
region
even
viral
gene
fleme
et
present
sequenc
analysi
indic
latter
hypothesi
correct
neuropathogen
jhm
depend
characterist
least
two
site
gene
complex
interact
differ
region
protein
like
influenc
viral
pathogenesi
chang
degre
viral
attenu
viva
virus
use
studi
includ
sever
jhm
variant
select
resist
neutral
mab
specif
protein
fleme
et
virul
neuropathogen
mice
list
tabl
parent
viru
jhmdl
largeplaqu
isol
wildtyp
jhm
strain
caus
mark
enceph
chronic
demyelin
survivor
stohlman
et
al
note
mab
monoclon
antibodi
ld
lethal
dose
mice
day
intracerebr
inocul
pfu
plaqu
form
unit
e
predominantli
enceph
predominantli
demyelin
fleme
et
al
fleme
et
al
variant
select
jhmdlwith
mab
caus
mark
demyelin
littl
enceph
fleme
et
al
variant
select
anoth
mab
nonpathogen
caus
minim
neuropatholog
fleme
eta
variant
select
directli
jhmdl
remain
encephalit
fleme
et
astrocytoma
cell
line
dbt
cell
deriv
mice
hirano
et
use
throughout
experi
virus
initi
plaquepurifi
three
time
propag
viru
stock
earli
passag
virus
passag
use
prepar
larg
amount
viru
biochem
studi
virus
passag
level
previous
use
pathogen
studi
fleme
et
fleme
et
variant
virus
grown
presenc
respect
mab
use
select
virus
mix
equal
amount
mab
tissu
cultur
supernat
incub
min
inocul
onto
confluent
dbt
cell
monolay
viru
adsorpt
hr
dulbecco
minim
essenti
medium
contain
fetal
calf
serum
ad
supernat
infect
cell
cultur
harvest
cytopath
effect
reach
harvest
virus
examin
resist
select
mab
ensur
virus
use
biochem
studi
maintain
origin
phenotyp
jhmdl
viru
grown
way
except
antibodi
use
virus
purifi
accord
procedur
modifi
makino
et
briefli
supernat
centrifug
rpm
min
clear
cell
debri
precipit
satur
ammonium
sulfat
least
hr
follow
centrifug
rpm
min
pellet
suspend
nte
naci
mtrishci
ph
mm
edta
suspens
centrifug
rpm
min
remov
undissolv
debri
supernat
subject
two
round
centrifug
discontinu
sucros
gradient
consist
sucros
nte
rpm
hr
beckman
rotor
virus
interfac
harvest
dilut
nte
pellet
centrifug
rpm
min
beckman
rotor
viru
pellet
resuspend
nte
isol
partial
revert
neutralizationescap
variant
variant
passag
dbt
cell
time
absenc
antibodi
virus
plaqueassay
plaqu
randomli
pick
purifi
three
round
plaqu
purif
sever
plaqu
examin
sensit
mab
larg
pool
revert
prepar
purifi
follow
procedur
describ
plaquepurifi
revert
design
vl
cdna
clone
viral
rna
extract
viru
suspens
nte
mix
equal
volum
proteinas
k
buffer
sd
edta
trishci
ph
naci
proteinas
k
pgmi
incub
min
rna
extract
twice
phenolchloroform
l
precipit
ethanol
pellet
rna
resuspend
distil
h
store
cdna
synthesi
viral
rna
first
denatur
mm
methylmercuri
room
temperatur
min
incub
min
pm
dntp
unit
taq
polymeras
cetu
pm
synthet
oligonucleotid
primer
first
second
primer
reaction
mixtur
overlaid
miner
oil
subject
cycl
amplif
cycl
consist
min
min
min
pcr
condit
adjust
slightli
differ
reaction
depend
size
target
sequenc
amplifi
pair
primer
use
pcr
product
resolv
oh
agaros
gel
tbe
buffer
mltrishci
ph
boric
acid
mm
edta
stain
ethidium
bromid
specif
product
band
cut
dna
extract
gel
phenol
chloroform
precipit
ethanol
pellet
suspend
distil
h
pcr
product
treat
unit
polynucleotid
kinas
boehringermanheim
buffer
contain
trishci
ph
mgci
mm
dlt
mm
spermidin
mm
atp
incub
min
phenolchloroform
extract
ethanol
precipit
pcr
product
bluntend
unit
dna
polymeras
boehringermanheim
min
buffer
contain
mtrishci
ph
mm
mgci
mm
dlt
mm
dntp
follow
booster
reaction
addit
unit
dna
polymeras
mm
dntp
anoth
min
phenolchloroform
extract
pcr
product
ligat
use
unit
dna
ligas
boehringermanheim
smal
site
plasmid
us
biochem
ligat
buffer
contain
trishci
ph
mgci
mm
dtt
mm
atp
ligat
mixtur
use
transform
compet
cell
brl
follow
manufactur
direct
dna
sequenc
dna
sequenc
perform
use
doublestrand
dnaof
plasmid
dideoxychain
termin
sequenc
perform
follow
procedur
outlin
sequenas
version
dna
sequenc
kit
us
biochem
reaction
product
analyz
polyacrylamid
gel
contain
urea
whole
gene
approxim
kb
length
clone
overlap
fragment
amplif
pcr
use
appropri
synthet
primer
sinc
deal
sever
viral
isol
presum
minor
differ
gene
crosscontamin
major
concern
avoid
problem
whenev
possibl
differ
pair
primer
use
clone
differ
viral
rna
distinguish
gene
fragment
obtain
viral
isol
case
altern
primer
avail
new
aliquot
reagent
use
isol
anoth
concern
enzym
use
name
revers
transcriptas
taq
polymeras
sequenas
may
gener
error
avoid
problem
clone
differ
cdna
synthesi
event
differ
pcr
event
multipl
clone
sequenc
isol
fulllength
sequenc
initi
obtain
two
differ
dna
clone
differ
sequenc
identifi
initi
sequenc
studi
sequenc
clone
consist
chang
consid
bona
fide
mutat
sequenc
variat
confirm
direct
rna
sequenc
use
purifi
virion
rna
banner
et
complet
sequenc
gene
parent
jhmdl
neutralizationescap
variant
summar
schemat
fig
gene
jhmdl
nearli
ident
parker
et
nucleotid
differ
amino
acid
differ
tabl
code
capac
amino
acid
ident
mhv
schmidt
et
al
luytj
et
al
predict
proteolyt
cleavag
site
amino
acid
arg
ser
gene
deriv
jhmdl
select
mab
appear
consist
two
popul
clone
contain
nucleotid
differ
jhmdl
locat
nucleotid
nt
chang
codon
ctc
tx
leu
phe
besid
mutat
minor
clone
contain
four
addit
mutat
ntermin
note
sequenc
parker
et
al
note
sequenc
variat
found
consist
two
cdna
clone
deriv
differ
revers
transcript
event
polymeras
chain
reaction
contrast
sequenc
variat
jhmdl
found
randomli
differ
clone
frequenc
indic
number
clone
show
altern
nucleotid
total
number
clone
sequenc
end
gene
tabl
locat
nt
chang
codon
ltt
tct
phe
ser
ccg
tcg
pro
ser
gga
gaa
gli
glu
ccg
ctg
pro
leu
respect
mutat
like
due
enzym
error
mutat
observ
two
clone
deriv
differ
revers
transcript
pcr
event
sequenc
multipl
jhmdlderiv
clone
also
show
heterogen
sever
differ
nucleotid
posit
tabl
differ
sequenc
variat
observ
sinc
consist
differ
jhmdl
nt
mutat
like
respons
resist
mab
howev
contribut
sequenc
microheterogen
tabl
phenotyp
virus
could
rule
note
minor
sequenc
variat
ntermin
half
diverg
part
gene
de
groot
et
variant
deriv
select
mab
fleme
et
sequenc
analysi
show
delet
ntermin
half
nt
correspond
acid
delet
accompani
delet
two
amino
acid
arginin
tyrosin
junction
delet
convert
histidin
expect
nt
variant
remain
ttc
similar
also
similar
small
number
clone
contain
sever
addit
point
mutat
upstream
downstream
region
delet
data
shown
sequenc
variat
differ
observ
variant
sinc
delet
consist
chang
observ
clone
like
respons
phenotyp
differ
confirm
delet
ntermin
half
respons
viral
resist
mab
sequenc
gene
deriv
directli
jhmdl
select
mab
fleme
et
surpris
delet
instead
two
point
mutat
consist
detect
downstream
delet
site
one
nt
chang
codon
tca
tta
ser
leu
one
nt
chang
codon
aag
aat
ly
asn
chang
local
around
hypetvari
region
de
groot
et
al
parker
et
banner
et
protein
result
suggest
mutat
includ
delet
point
mutat
region
like
respons
viral
resist
mab
nt
remain
ctc
similar
jhmdl
consist
fact
directli
deriv
jhmdl
determin
whether
mutat
nt
microheterogen
sl
respons
viral
resist
mab
pathogen
viru
attempt
isol
revert
variant
passag
dbt
cell
absenc
mab
virus
randomli
select
plaqu
sinc
parent
jhmdl
grew
better
neutralizationresist
variant
unpublish
observ
reason
revert
would
becom
predomin
popul
serial
viral
passag
absenc
select
pressur
inde
plaquepurifi
virus
isol
way
partial
sensit
mab
data
shown
titer
reduc
mab
approxim
log
howev
none
virus
examin
n
complet
revert
level
seen
parent
jhmdl
whose
titer
reduc
mab
approxim
loglo
fleme
et
al
fleme
et
al
sequenc
analysi
multipl
clone
seven
partial
revert
show
retain
sequenc
nt
consist
differ
observ
jhmdl
one
revert
chosen
complet
sequenc
viru
consist
chang
second
site
nt
chang
codon
aat
asn
agt
ser
sinc
none
revert
complet
restor
phenotyp
parent
jhmdl
logic
explan
differ
region
protein
may
cooper
contribut
resist
viru
neutral
mab
find
nt
mutat
retain
partial
revett
suggest
site
major
contribut
resist
mab
preliminari
viral
pathogen
studi
intracerebr
inocul
mice
reveal
vlo
ld
approxim
pfu
similar
contrast
jhmdl
ld
pfu
tabl
fleme
et
similar
partial
revert
viru
primarili
caus
demyelin
littl
enceph
result
suggest
second
site
mutat
sl
region
alter
pathogen
viru
mutat
nt
respons
neuropathogen
jhm
virus
sequenc
analysi
mabescap
mutant
jhm
indic
mutant
select
mab
point
mutat
region
spike
protein
contrast
mab
use
select
mutant
point
mutat
delet
sl
within
nt
observ
previou
attempt
map
bind
site
mab
fail
weismil
eta
studi
suggest
mab
would
bind
sl
mab
would
bind
find
consist
recent
studi
measur
direct
bind
mhvspecif
mab
also
indic
bound
p
talbot
person
commun
bind
site
close
neutral
epitop
identifi
laboratori
luytj
et
al
routledg
et
al
interestingli
mutat
nt
chang
code
amino
acid
leu
phe
affect
one
three
amino
acid
critic
fusion
function
protein
gallagh
et
al
howev
variant
induc
fusion
grown
dbt
cell
data
shown
expect
sinc
loss
fusion
activ
requir
simultan
mutat
three
amino
acid
gallagh
er
al
nevertheless
find
show
amino
acid
play
import
role
fusion
activ
neuropathogen
mhv
region
sl
delet
point
mutat
mutant
correspond
previous
identifi
hypervari
site
sl
parker
et
banner
et
site
underw
frequent
delet
point
mutat
upon
viral
passag
tissu
cultur
anim
dalziel
eta
banner
et
gallagh
et
although
precis
site
delet
point
mutat
differ
among
variant
gener
area
ie
near
cterminu
sl
previous
buchmeier
laboratori
also
report
differ
type
mutat
among
neutralizationescap
variant
deriv
use
monoclon
antibodi
differ
one
use
studi
parker
er
gallagh
et
al
variant
either
delet
point
mutat
area
sl
result
togeth
suggest
region
repres
immunodomin
highli
variabl
site
although
bind
site
mab
directli
determin
taken
togeth
previou
studi
analysi
indic
least
two
site
play
critic
role
mhv
neuropathogenesi
hypervari
sl
region
within
nt
second
region
around
nt
preserv
parent
wildtyp
sequenc
region
appear
requir
abil
viru
caus
fatal
enceph
sinc
mutat
either
site
reduc
neurovirul
mutat
convert
parent
jhm
viru
highli
encephalit
highli
demyelin
viru
addit
mutat
delet
sl
led
essenti
nondemyelin
viru
fleme
et
al
tabl
result
consist
interpret
site
sl
tightli
associ
demyelin
site
respons
enceph
howev
interpret
unlik
sinc
neutralizationresist
mutant
delet
domain
sl
still
caus
demyelin
dalziel
et
al
gallagh
et
thu
hypothes
virtual
inabl
caus
demyelin
enceph
fleme
et
due
viral
attenu
occur
sl
determin
lost
mutat
interpret
consist
find
mutat
variant
mutat
sl
mutant
dalziel
et
al
led
similar
demyelin
phenotyp
also
consist
current
understand
biolog
activ
protein
protein
form
peplom
project
surfac
mhv
virion
thu
ideal
posit
influenc
pathogenesi
alter
viral
attach
cellular
receptor
interact
immun
system
fusion
cellular
membran
collin
et
sturman
et
perhap
mechan
influenc
viral
stabil
uncoat
spread
intracerebr
inocul
parent
jhmdl
rapidli
gain
entri
glia
neuron
throughout
cn
thu
abl
caus
fatal
panenceph
weiner
knobler
et
contrast
mabselect
jhm
mutant
less
abl
spread
neuron
virul
thu
drastic
reduc
fleme
et
howev
virus
abl
infect
glial
cell
white
matter
brain
spinal
cord
presum
requir
viral
entri
replic
glial
cell
less
stringent
neuron
infect
differenti
entri
may
reflect
presenc
differ
receptor
util
wildtyp
viru
versu
select
variant
addit
suscept
differ
neural
cell
jhm
known
affect
development
stage
differ
cell
speci
host
factor
pasick
dale
case
infect
jhm
mutant
immun
respons
clear
viru
white
matter
day
postinocul
deleteri
consequ
induc
myelin
loss
wang
et
al
thu
appar
increas
abil
caus
demyelin
shown
similar
variant
dalziel
et
wege
et
probabl
due
unmask
potenti
parent
viru
usual
hidden
virul
abil
mutat
differ
site
affect
biolog
properti
protein
demonstr
sequenc
analysi
partial
revert
second
site
mutat
partial
restor
mab
sensit
viru
local
sl
contrast
origin
mutat
studi
suggest
two
steric
separ
site
one
globular
portion
heptad
repeat
region
stalk
portion
accord
comput
model
de
groot
et
al
two
differ
subunit
could
interact
effect
also
illustr
antibodi
sensit
former
roughli
one
loglo
resist
latter
mab
fleme
eta
suggest
second
mutat
alter
conform
first
site
interestingli
partial
revert
retain
pathogen
properti
parent
variant
furthermor
variant
retain
abil
caus
enceph
tabl
result
suggest
antibodi
bind
pathogen
properti
protein
dissoci
studi
also
suggest
possibl
presenc
sequenc
microheterogen
mhv
tabl
data
shown
virus
initi
plaquepurifi
amplifi
limit
passag
obtain
suffici
viru
titer
molecular
clone
sequenc
sequenc
variat
like
result
pcr
clone
error
howev
sever
nucleotid
variat
consist
note
repeat
pcr
product
furthermor
sequenc
microheterogen
locat
mostli
sl
hypervari
region
banner
et
de
groot
et
suggest
observ
sequenc
variat
repres
variat
rna
sinc
plaquepurifi
virus
need
propag
either
biochem
pathogen
studi
sequenc
microheterogen
like
inher
properti
viru
popul
possibl
contribut
sequenc
microheterogen
viral
neuropathogen
clear
present
time
conclus
studi
suggest
least
two
region
gene
play
critic
role
jhm
neuropathogenesi
region
near
nt
sl
segment
nt
segment
antigen
studi
indic
site
may
close
link
protein
may
influenc
spatial
proxim
steric
effect
fleme
et
al
virus
parent
jhm
sequenc
may
infect
cell
type
region
cn
result
fatal
panenceph
either
site
alter
viral
infect
limit
glial
cell
white
matter
subsequ
immun
attack
wang
et
al
virusinduc
cytolysi
lead
demyelin
site
affect
viru
show
limit
distribut
presum
contain
immun
system
earli
stage
pathogenesi
probabl
domain
may
also
contribut
viral
pathogen
addit
although
gene
consid
import
influenc
pathogen
viral
gene
hemagglutininesteras
la
monica
et
yokomori
et
al
local
portion
genom
lavi
et
may
also
extent
contribut
viral
pathogen
